What SAMHSA’s 2026 988 funding could change first in local communities
SAMHSA’s 2026 988 funding may show up first as faster answers, more local routing, and stronger follow-up, not instant growth in in-person crisis care.
Local Health News and Alerts
-
-
What the CY 2026 Medicare physician fee schedule could mean for patient access, preventive care, and physician practices
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
-
What the New CMS Prior-Authorization Reports Can and Cannot Tell Patients in 2026
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
-
Minnesota’s Medicaid funding deferral: Why providers may feel the strain before patients do
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
-
FDA Is Tightening the Rules on Compounded GLP-1 Drugs. What That Could Mean for Access, Safety, and Cost
FDA’s 2026 crackdown on mass-marketed compounded GLP-1s could tighten safety oversight but also shrink cheaper options for people struggling to afford approved drugs.
-
Health Equity in the 2025-2030 Dietary Guidelines: Where Families May Actually Feel It
The 2025-2030 Dietary Guidelines talk a lot about “real food,” but the bigger everyday question is whether healthy choices become easier to afford, find, and fit real life. That is where the Advisory Committee’s health-equity lens may matter most.
-
What the new 2025-2030 Dietary Guidelines really mean for your plate: cut ultra-processed foods first, and read the protein debate carefully
The new federal dietary guidelines matter far beyond your kitchen. For most people, the clearest takeaway is to cut back on highly processed foods, sugary drinks, and refined carbs before fixating on the newer, more debated protein and dairy shifts.
-
What the FDA says it is changing about infant-formula recalls after the ByHeart botulism outbreak
After the ByHeart-linked infant botulism outbreak, the FDA says it is tightening recall follow-through, making formula information easier for families to find, and expanding sampling and surveillance. Here is what changed, what parents should watch for, and what is still not fully known.
-
ByHeart formula botulism outbreak is over, but the recall is not: what parents should know now
Federal officials say the ByHeart-linked infant botulism outbreak is over, but all ByHeart Whole Nutrition infant formula remains recalled. Here’s what parents should do now, which symptoms need urgent care, and what is still unknown.
-
What the Star Princess norovirus outbreak teaches travelers about staying off the ship, reporting symptoms fast, and why extra cleaning is not enough
The March 2026 Star Princess outbreak offers a practical lesson for cruise travelers: do not board while sick, report even mild vomiting or diarrhea quickly, and do not assume deep cleaning alone can stop norovirus.
-
CDC’s Latest Norovirus Data Suggest a Busy but Not Record-Breaking Season—and the Prevention Steps That Matter Most
The latest CDC outbreak data point to an active 2025–2026 norovirus season, with an early fall rise and a peak in early February. But the numbers do not show the biggest weekly spikes seen in the historical comparison. Here’s what the data do and do not mean, plus the prevention steps that matter most at home, school, work, and around food.
-
More U.S. Babies Are Entering RSV Season Protected: How Maternal Vaccination and Infant Antibodies Are Working in 2025-2026
As of February 2026, CDC estimated that 65.1% of U.S. infants born since April 1, 2025 were already protected against RSV through maternal immunization only or an infant monoclonal antibody, with another 9.1% of parents saying they definitely planned to get the infant product. For most babies, protection comes from one route or the other, not both. ([cdc.gov](https://www.cdc.gov/rsvvaxview/dashboard/index.html))
-
Updated RSV guidance in 2026: Which older adults should get vaccinated, who can wait, and why
CDC says adults 75 and older should get one RSV shot, and adults 50 to 74 should get it only if they have certain high-risk conditions, frailty, or nursing home residence. For healthy adults under 75, current guidance usually means you can wait. ([cdc.gov](https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html))
-
Bird flu in wastewater: what an H5 detection does and does not mean for your risk
CDC says an H5 signal in wastewater can be an early warning worth investigating, but it cannot show whether the source is humans, animals, or animal products such as milk. That means a dot on the map does not by itself prove human cases or community spread, and CDC said on April 3, 2026, that current flu surveillance still showed no indicators of unusual influenza activity in people, including avian influenza A(H5). ([cdc.gov](https://www.cdc.gov/nwss/rv/wwd-h5.html))
-
CDC’s latest H5 bird flu update: what is known, what is not, and why person-to-person spread still matters
CDC’s April 3, 2026 H5 update says there are still no signs of unusual flu activity in people. Here is what 71 U.S. cases do and do not mean, and why worker monitoring still matters.
-
Trivalent flu shots didn’t drop the ball: what the 2025-26 switch really meant for protection this season
The move to trivalent flu vaccines did not appear to leave Americans unprotected against a major circulating strain. This season’s weaker flu-shot performance looks more tied to drifted viruses, especially H3N2, than to dropping the long-absent B/Yamagata component.
-
Flu Season Is Easing, but Risk Isn’t Over: What Families, Older Adults, and High-Risk Patients Should Do Right Now
CDC says U.S. flu activity is falling but still elevated as of March 27, 2026. This season has brought unusually high hospitalization burden, high pediatric severity, and weaker-than-usual vaccine performance against a drifted H3N2 strain—yet vaccination and early antiviral treatment still matter right now. ([cdc.gov](https://www.cdc.gov/fluview/surveillance/2026-week-11.html))
-
CDC says U.S. measles cases hit 1,671 in 2026: what families and schools should do now about records, exclusions, and catch-up MMR shots
CDC’s April 3, 2026 measles update shows higher U.S. case counts, but not a new national vaccine schedule. The practical message for families and schools is simpler: check written MMR records now, understand who may be excluded after an exposure, and move quickly if catch-up vaccination or post-exposure treatment may be needed.
-
No Symptoms, Still Worth the Check: What Adults Should Know About Oral Cancer Screening in 2026
An oral cancer screening during a dental visit is usually a simple look-and-feel exam of the mouth, throat area, and neck. It can help spot suspicious changes early, even though current evidence still does not prove that screening symptom-free adults lowers deaths.
-
Can Rheumatoid Arthritis Be Delayed? What a New Abatacept Study Really Found
A January 2026 follow-up study suggests one year of abatacept may delay rheumatoid arthritis in a narrowly defined high-risk group, but it did not prove permanent prevention or create a new plan for everyday joint aches.
-
U.S. Measles Cases Are Still Rising in 2026: What Families Should Check Now
Measles is still vaccine-preventable, but it spreads quickly when travel-related cases reach communities with lower local vaccination coverage. CDC says confirmed U.S. cases remain high in early 2026, and a new JAMA Network Open study suggests delayed early childhood shots can be an early warning sign that a child may also miss MMR on time.
-
Are Children’s Vaccines Still Covered? What the 2026 Schedule Fight Means for Parents
A plain-language guide to what changed in 2026, which vaccine schedule many pediatric practices and states are using, and how coverage works now for private insurance and VFC.
End of content
End of content
